Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuti Chernajovsky

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Arthritis Research & Therapy|November 10, 2005
Gene therapy for arthritis--where do we stand?Yuti Chernajovsky
Rheumatology (Oxford, England)|October 11, 2011
The importance of understanding the molecular mechanisms of resistance to biologicsYuti Chernajovsky
Current Opinion in Pharmacology|July 6, 2007
Novel delivery methods to achieve immunomodulationDavid J Gould, Yuti Chernajovsky
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Endogenous GATA factors bind the core sequence of the tetO and influence gene regulation with the tetracycline systemDavid J Gould, Yuti Chernajovsky
Rheumatology (Oxford, England)|June 16, 2011
Comment on: Low TNF-induced NF-κB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndromeMark D Turner, Yuti Chernajovsky
Discovery Medicine|August 14, 2010
Targeting therapeutic molecules to sites of diseaseYuti Chernajovsky, Sandrine Vessillier, Gill Adams
BMJ (Clinical Research Ed.)|January 21, 2006
Fighting cancer with oncolytic virusesYuti Chernajovsky, Lorna Layward, Nicholas Lemoine
Protein Engineering, Design & Selection : PEDS|February 15, 2005
Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3Sandrine Vessillier, Gill Adams, Yuti Chernajovsky
Journal of Biotechnology|July 28, 2012
Increased disulphide dimer formation of latent associated peptide fusions of TGF-β by addition of L-cystineLisa M Mullen, Gill Adams, Yuti Chernajovsky
Arthritis Research & Therapy|April 3, 2004
Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmidDavid J Gould, Carly Bright, Yuti Chernajovsky
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Arthritis Research & Therapy|November 10, 2005
Gene therapy for arthritis--where do we stand?Yuti Chernajovsky
Rheumatology (Oxford, England)|October 11, 2011
The importance of understanding the molecular mechanisms of resistance to biologicsYuti Chernajovsky
Current Opinion in Pharmacology|July 6, 2007
Novel delivery methods to achieve immunomodulationDavid J Gould, Yuti Chernajovsky
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Endogenous GATA factors bind the core sequence of the tetO and influence gene regulation with the tetracycline systemDavid J Gould, Yuti Chernajovsky
Rheumatology (Oxford, England)|June 16, 2011
Comment on: Low TNF-induced NF-κB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndromeMark D Turner, Yuti Chernajovsky
Discovery Medicine|August 14, 2010
Targeting therapeutic molecules to sites of diseaseYuti Chernajovsky, Sandrine Vessillier, Gill Adams
BMJ (Clinical Research Ed.)|January 21, 2006
Fighting cancer with oncolytic virusesYuti Chernajovsky, Lorna Layward, Nicholas Lemoine
Protein Engineering, Design & Selection : PEDS|February 15, 2005
Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3Sandrine Vessillier, Gill Adams, Yuti Chernajovsky
Journal of Biotechnology|July 28, 2012
Increased disulphide dimer formation of latent associated peptide fusions of TGF-β by addition of L-cystineLisa M Mullen, Gill Adams, Yuti Chernajovsky
Arthritis Research & Therapy|April 3, 2004
Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmidDavid J Gould, Carly Bright, Yuti Chernajovsky
Pageof 5